Bastiano Sanna, EVP, Cell & Genetic Therapies at VERTEX PHARMACEUTICALS INC / MA (VRTX), sold 4,362 shares at $301.11 ($1.3M) on 2023-02-14, disclosed to the SEC on 2023-02-16.
Open-market sale of $1.3M VRTX by EVP, Cell & Genetic Therapies. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $300.29 | 1,902 | $571K | 43.6% |
| 2 | $300.29 | 1,902 | $571K | 43.6% |
| 3 | $301.11 | 279 | $84K | 6.4% |
| 4 | $301.11 | 279 | $84K | 6.4% |
| Total | $300.40 avg | 4,362 | $1.3M | 100% |
| Filing → |
| VRTX | SELL | 2023-04-14 | $4.9M | — | Filing → |
| VRTX | SELL | 2023-04-06 | $231K | — | Filing → |
| VRTX | SELL | 2023-03-20 | $1.7M | — | Filing → |